Exenatide versus Insulin Lispro Added to Basal Insulin in a Subgroup of Korean Patients with Type 2 Diabetes Mellitus.

Kun-Ho YoonElise HardyJenny Han

Published in: Diabetes & metabolism journal (2016)

This analysis found treatment with exenatide twice daily improved glycemic control without weight gain in Korean patients with T2DM unable to achieve glycemic control on metformin plus basal insulin.

Keyphrases

glycemic control
type diabetes
weight gain
blood glucose
weight loss
end stage renal disease
insulin resistance
body mass index
ejection fraction
newly diagnosed
birth weight
chronic kidney disease
physical activity
prognostic factors
clinical trial
adipose tissue
open label
data analysis
phase iii